Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)

Leukemia. 2006 May;20(5):905-7. doi: 10.1038/sj.leu.2404158.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anthracyclines / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Arsenic Trioxide
  • Arsenicals / therapeutic use
  • Combined Modality Therapy
  • Europe
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / diagnosis
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Male
  • Middle Aged
  • Oxides / therapeutic use
  • Prognosis
  • Recurrence
  • Risk Factors
  • Treatment Outcome
  • Tretinoin / administration & dosage*

Substances

  • Anthracyclines
  • Arsenicals
  • Oxides
  • Tretinoin
  • Arsenic Trioxide